 | • レポートコード：MRC2312MG09859 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、69ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の大動脈狭窄症市場規模と予測を収録しています。・世界の大動脈狭窄症市場：売上、2018年-2023年、2024年-2029年 ・世界の大動脈狭窄症市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の大動脈狭窄症市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「経カテーテル的大動脈弁移植術（TAVI）」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 大動脈狭窄症のグローバル主要企業は、Abbott Laboratories、 AstraZeneca Plc.、 Boston Scientific Corporation、 Coroneo、 CryoLife, Inc.、 Edwards Lifesciences Corporation、 JenaValve Technology, Inc.、 LifeNet Health、 LivaNova PLC、 Medtronic Plc、 Meril Life Sciences Pvt. Ltd.、 Thubrikar Aortic Valveなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、大動脈狭窄症のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の大動脈狭窄症市場：タイプ別、2018年-2023年、2024年-2029年 世界の大動脈狭窄症市場：タイプ別市場シェア、2022年 ・経カテーテル的大動脈弁移植術（TAVI）、外科的大動脈弁置換術（SAVR） 世界の大動脈狭窄症市場：用途別、2018年-2023年、2024年-2029年 世界の大動脈狭窄症市場：用途別市場シェア、2022年 ・先天性大動脈狭窄症、後天性大動脈狭窄症 世界の大動脈狭窄症市場：地域・国別、2018年-2023年、2024年-2029年 世界の大動脈狭窄症市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における大動脈狭窄症のグローバル売上、2018年-2023年 ・主要企業における大動脈狭窄症のグローバル売上シェア、2022年 ・主要企業における大動脈狭窄症のグローバル販売量、2018年-2023年 ・主要企業における大動脈狭窄症のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Abbott Laboratories、 AstraZeneca Plc.、 Boston Scientific Corporation、 Coroneo、 CryoLife, Inc.、 Edwards Lifesciences Corporation、 JenaValve Technology, Inc.、 LifeNet Health、 LivaNova PLC、 Medtronic Plc、 Meril Life Sciences Pvt. Ltd.、 Thubrikar Aortic Valve ************************************************************* ・調査・分析レポートの概要 大動脈狭窄症市場の定義 市場セグメント 世界の大動脈狭窄症市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の大動脈狭窄症市場規模 世界の大動脈狭窄症市場規模：2022年 VS 2029年 世界の大動脈狭窄症市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの大動脈狭窄症の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の大動脈狭窄症製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：経カテーテル的大動脈弁移植術（TAVI）、外科的大動脈弁置換術（SAVR） 大動脈狭窄症のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：先天性大動脈狭窄症、後天性大動脈狭窄症 大動脈狭窄症の用途別グローバル売上・予測 ・地域別市場分析 地域別大動脈狭窄症市場規模 2022年と2029年 地域別大動脈狭窄症売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Abbott Laboratories、 AstraZeneca Plc.、 Boston Scientific Corporation、 Coroneo、 CryoLife, Inc.、 Edwards Lifesciences Corporation、 JenaValve Technology, Inc.、 LifeNet Health、 LivaNova PLC、 Medtronic Plc、 Meril Life Sciences Pvt. Ltd.、 Thubrikar Aortic Valve ... |
This research report provides a comprehensive analysis of the Aortic Stenosis market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Aortic Stenosis market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Aortic Stenosis, challenges faced by the industry, and potential opportunities for market players.
The global Aortic Stenosis market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Aortic Stenosis market presents opportunities for various stakeholders, including Congenital Aortic Stenosis, Acquired Aortic Stenosis. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Aortic Stenosis market. Additionally, the growing consumer demand present avenues for market expansion.
The global Aortic Stenosis market was valued at US$ 5091.3 million in 2022 and is projected to reach US$ 10300 million by 2029, at a CAGR of 10.5% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Aortic Stenosis market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Aortic Stenosis market.
Market Overview: The report provides a comprehensive overview of the Aortic Stenosis market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Transcatheter Aortic Valve Implantation (TAVI), Surgical Aortic Valve Replacement (SAVR)), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Aortic Stenosis market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Aortic Stenosis market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Aortic Stenosis market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Aortic Stenosis market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Aortic Stenosis market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Aortic Stenosis market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Aortic Stenosis, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Aortic Stenosis market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Aortic Stenosis market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Transcatheter Aortic Valve Implantation (TAVI)
Surgical Aortic Valve Replacement (SAVR)
Market segment by Application
Congenital Aortic Stenosis
Acquired Aortic Stenosis
Global Aortic Stenosis Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Abbott Laboratories
AstraZeneca Plc.
Boston Scientific Corporation
Coroneo
CryoLife, Inc.
Edwards Lifesciences Corporation
JenaValve Technology, Inc.
LifeNet Health
LivaNova PLC
Medtronic Plc
Meril Life Sciences Pvt. Ltd.
Thubrikar Aortic Valve
Outline of Major Chapters:
Chapter 1: Introduces the definition of Aortic Stenosis, market overview.
Chapter 2: Global Aortic Stenosis market size in revenue.
Chapter 3: Detailed analysis of Aortic Stenosis company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Aortic Stenosis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Aortic Stenosis Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Aortic Stenosis Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Aortic Stenosis Overall Market Size
2.1 Global Aortic Stenosis Market Size: 2022 VS 2029
2.2 Global Aortic Stenosis Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Aortic Stenosis Players in Global Market
3.2 Top Global Aortic Stenosis Companies Ranked by Revenue
3.3 Global Aortic Stenosis Revenue by Companies
3.4 Top 3 and Top 5 Aortic Stenosis Companies in Global Market, by Revenue in 2022
3.5 Global Companies Aortic Stenosis Product Type
3.6 Tier 1, Tier 2 and Tier 3 Aortic Stenosis Players in Global Market
3.6.1 List of Global Tier 1 Aortic Stenosis Companies
3.6.2 List of Global Tier 2 and Tier 3 Aortic Stenosis Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Aortic Stenosis Market Size Markets, 2022 & 2029
4.1.2 Transcatheter Aortic Valve Implantation (TAVI)
4.1.3 Surgical Aortic Valve Replacement (SAVR)
4.2 By Type – Global Aortic Stenosis Revenue & Forecasts
4.2.1 By Type – Global Aortic Stenosis Revenue, 2018-2023
4.2.2 By Type – Global Aortic Stenosis Revenue, 2024-2029
4.2.3 By Type – Global Aortic Stenosis Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Aortic Stenosis Market Size, 2022 & 2029
5.1.2 Congenital Aortic Stenosis
5.1.3 Acquired Aortic Stenosis
5.2 By Application – Global Aortic Stenosis Revenue & Forecasts
5.2.1 By Application – Global Aortic Stenosis Revenue, 2018-2023
5.2.2 By Application – Global Aortic Stenosis Revenue, 2024-2029
5.2.3 By Application – Global Aortic Stenosis Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Aortic Stenosis Market Size, 2022 & 2029
6.2 By Region – Global Aortic Stenosis Revenue & Forecasts
6.2.1 By Region – Global Aortic Stenosis Revenue, 2018-2023
6.2.2 By Region – Global Aortic Stenosis Revenue, 2024-2029
6.2.3 By Region – Global Aortic Stenosis Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Aortic Stenosis Revenue, 2018-2029
6.3.2 US Aortic Stenosis Market Size, 2018-2029
6.3.3 Canada Aortic Stenosis Market Size, 2018-2029
6.3.4 Mexico Aortic Stenosis Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Aortic Stenosis Revenue, 2018-2029
6.4.2 Germany Aortic Stenosis Market Size, 2018-2029
6.4.3 France Aortic Stenosis Market Size, 2018-2029
6.4.4 U.K. Aortic Stenosis Market Size, 2018-2029
6.4.5 Italy Aortic Stenosis Market Size, 2018-2029
6.4.6 Russia Aortic Stenosis Market Size, 2018-2029
6.4.7 Nordic Countries Aortic Stenosis Market Size, 2018-2029
6.4.8 Benelux Aortic Stenosis Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Aortic Stenosis Revenue, 2018-2029
6.5.2 China Aortic Stenosis Market Size, 2018-2029
6.5.3 Japan Aortic Stenosis Market Size, 2018-2029
6.5.4 South Korea Aortic Stenosis Market Size, 2018-2029
6.5.5 Southeast Asia Aortic Stenosis Market Size, 2018-2029
6.5.6 India Aortic Stenosis Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Aortic Stenosis Revenue, 2018-2029
6.6.2 Brazil Aortic Stenosis Market Size, 2018-2029
6.6.3 Argentina Aortic Stenosis Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Aortic Stenosis Revenue, 2018-2029
6.7.2 Turkey Aortic Stenosis Market Size, 2018-2029
6.7.3 Israel Aortic Stenosis Market Size, 2018-2029
6.7.4 Saudi Arabia Aortic Stenosis Market Size, 2018-2029
6.7.5 UAE Aortic Stenosis Market Size, 2018-2029
7 Aortic Stenosis Companies Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Company Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Aortic Stenosis Major Product Offerings
7.1.4 Abbott Laboratories Aortic Stenosis Revenue in Global Market (2018-2023)
7.1.5 Abbott Laboratories Key News & Latest Developments
7.2 AstraZeneca Plc.
7.2.1 AstraZeneca Plc. Company Summary
7.2.2 AstraZeneca Plc. Business Overview
7.2.3 AstraZeneca Plc. Aortic Stenosis Major Product Offerings
7.2.4 AstraZeneca Plc. Aortic Stenosis Revenue in Global Market (2018-2023)
7.2.5 AstraZeneca Plc. Key News & Latest Developments
7.3 Boston Scientific Corporation
7.3.1 Boston Scientific Corporation Company Summary
7.3.2 Boston Scientific Corporation Business Overview
7.3.3 Boston Scientific Corporation Aortic Stenosis Major Product Offerings
7.3.4 Boston Scientific Corporation Aortic Stenosis Revenue in Global Market (2018-2023)
7.3.5 Boston Scientific Corporation Key News & Latest Developments
7.4 Coroneo
7.4.1 Coroneo Company Summary
7.4.2 Coroneo Business Overview
7.4.3 Coroneo Aortic Stenosis Major Product Offerings
7.4.4 Coroneo Aortic Stenosis Revenue in Global Market (2018-2023)
7.4.5 Coroneo Key News & Latest Developments
7.5 CryoLife, Inc.
7.5.1 CryoLife, Inc. Company Summary
7.5.2 CryoLife, Inc. Business Overview
7.5.3 CryoLife, Inc. Aortic Stenosis Major Product Offerings
7.5.4 CryoLife, Inc. Aortic Stenosis Revenue in Global Market (2018-2023)
7.5.5 CryoLife, Inc. Key News & Latest Developments
7.6 Edwards Lifesciences Corporation
7.6.1 Edwards Lifesciences Corporation Company Summary
7.6.2 Edwards Lifesciences Corporation Business Overview
7.6.3 Edwards Lifesciences Corporation Aortic Stenosis Major Product Offerings
7.6.4 Edwards Lifesciences Corporation Aortic Stenosis Revenue in Global Market (2018-2023)
7.6.5 Edwards Lifesciences Corporation Key News & Latest Developments
7.7 JenaValve Technology, Inc.
7.7.1 JenaValve Technology, Inc. Company Summary
7.7.2 JenaValve Technology, Inc. Business Overview
7.7.3 JenaValve Technology, Inc. Aortic Stenosis Major Product Offerings
7.7.4 JenaValve Technology, Inc. Aortic Stenosis Revenue in Global Market (2018-2023)
7.7.5 JenaValve Technology, Inc. Key News & Latest Developments
7.8 LifeNet Health
7.8.1 LifeNet Health Company Summary
7.8.2 LifeNet Health Business Overview
7.8.3 LifeNet Health Aortic Stenosis Major Product Offerings
7.8.4 LifeNet Health Aortic Stenosis Revenue in Global Market (2018-2023)
7.8.5 LifeNet Health Key News & Latest Developments
7.9 LivaNova PLC
7.9.1 LivaNova PLC Company Summary
7.9.2 LivaNova PLC Business Overview
7.9.3 LivaNova PLC Aortic Stenosis Major Product Offerings
7.9.4 LivaNova PLC Aortic Stenosis Revenue in Global Market (2018-2023)
7.9.5 LivaNova PLC Key News & Latest Developments
7.10 Medtronic Plc
7.10.1 Medtronic Plc Company Summary
7.10.2 Medtronic Plc Business Overview
7.10.3 Medtronic Plc Aortic Stenosis Major Product Offerings
7.10.4 Medtronic Plc Aortic Stenosis Revenue in Global Market (2018-2023)
7.10.5 Medtronic Plc Key News & Latest Developments
7.11 Meril Life Sciences Pvt. Ltd.
7.11.1 Meril Life Sciences Pvt. Ltd. Company Summary
7.11.2 Meril Life Sciences Pvt. Ltd. Business Overview
7.11.3 Meril Life Sciences Pvt. Ltd. Aortic Stenosis Major Product Offerings
7.11.4 Meril Life Sciences Pvt. Ltd. Aortic Stenosis Revenue in Global Market (2018-2023)
7.11.5 Meril Life Sciences Pvt. Ltd. Key News & Latest Developments
7.12 Thubrikar Aortic Valve
7.12.1 Thubrikar Aortic Valve Company Summary
7.12.2 Thubrikar Aortic Valve Business Overview
7.12.3 Thubrikar Aortic Valve Aortic Stenosis Major Product Offerings
7.12.4 Thubrikar Aortic Valve Aortic Stenosis Revenue in Global Market (2018-2023)
7.12.5 Thubrikar Aortic Valve Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer